Evidence suggests that RAD-150 and other SARMs have anti-cancer properties:
A review of studies showed that SARMs inhibited breast cancer growth.
In patients with breast cancer, RAD-150 treatment suppresses the growth of cancer cells by blocking the effects of estrogen on tissues.
RAD-150 prevented the production of a protein called estrogen receptor 1 (ESR1), which is known to fuel cancer growth.